L26/P-335 The role of molecular profiling on investigating diagnostic approaches for chronic endometritis
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von K. Sfakianoudis und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can molecular profiles be indicative of discordant hysteroscopic and histological findings in chronic endometritis (CE) diagnosis? Summary answer Gene expression deciphers discordant findings of different CE diagnostic methods, indicating the value of molecular profiling in characterizing populations in the era of personalized medicine. What is known already Hysteroscopy with subsequent histological evaluation of endometrial tissue constitutes the gold standard diagnostic method for CE. Unified diagnostic criteria for hysteroscopy and immunohistology markers, namely CD-138 and MUM-1 have been established. However, intra-operative variability characterizes both methods leading to inconsistency in their findings, with hysteroscopy presenting with higher false-positive predictions. When challenged with conflicting diagnoses clinicians face decision-making uncertainty on treatment approach. It is of outmost importance to elucidate this discordance. Molecular biomarkers may play a critical role in identifying the cause of this discordance and provide insights on the investigation of CE population. Study design, size, duration A prospective, single-centre study was conducted between 04/2025-12/2025. A total of 116 women undergoing hysteroscopy and biopsy were recruited. Inclusion criteria were recurrent implantation failure, unexplained infertility or recurrent pregnancy loss. Women with uterine malformations and cancer diagnosis were excluded. According to hysteroscopic and histologic outcomes, 4 groups were formed: double positive, double negative, histology positive/hysteroscopy negative and histology negative/hysteroscopy positive. Published unified criteria for hysteroscopy and CD-138 and MUM-1 for histology were employed. Participants/materials, setting, methods Endometrial tissue samples were analyzed for the expression of JCHAIN and IGHG4, involved in the structure and function of immunoglobulins, IFN-g and NF-κΒ, which are involved in immunity response, TVP23A which is highly expressed in macrophages, and GAPDH as the reference gene by qPCR. For the evaluation of the prognostic model the receiver operating characteristics (ROCs) curve was employed and the area under the curve (AUC) was estimated along with sensitivity and specificity. Main results and the role of chance A total of 116 women were classified as double positive (n = 38), double negative (n = 31), histology positive/hysteroscopy negative (n = 19) and histology negative/hysteroscopy positive (n = 28). Gene expressions were normalized according to GAPDH expression. To evaluate the predictive effectiveness of these 5 genes we considered patients with confirmed histological CE as the gold standard. According to this, the 5 genes achieved an AUC of 0.761 (95% CI: 0.674-0.848). Then these genes were evaluated on their discrimination capabilities between histology positive/Hysteroscopy negative cases and vice versa (47 patients). The 5 gene model achieved an AUC of 0.944 (95% CI: 0.885-1), with sensitivity at 89.5% and specificity at 85.7%. This model was validated employing the Leave-One-Out Cross-Validation (LOOCV), upholding a significant prognostic performance of an AUC of 0.831. The genes with the highest prognostic performance were IGHG4 (ΔCt cut-off: 6.67, AUC:0.84, sensitivity: 78.9%, specificity: 89.3%) and JCHAIN (ΔCt cut-off: 6.35, AUC:0.82 sensitivity: 63.2%, specificity: 89.3%). Following these results a gene-signature score (0-100) was developed with higher values indicating higher expression levels of the 5 genes. The two discordant groups presented with significantly different gene signature scores (Hysteroscopy Positive: 23.5±17 vs Histology Positive: 65.6±21.8; p < 0.001). Limitations, reasons for caution The study being conducted in a single centre along with the relatively small sample size may constitute reasons for caution when interpreting the results sourced herein. Additionally, the different sample size among the 4 groups may be considered as another limitation of the study. Wider implications of the findings This gene expression model showcased that discordant results between histology and hysteroscopy correspond to different molecular profiles. Molecular profiling through assessment of immune-related genes offers population characterization towards a robust diagnosis. Further validation studies investigating clinical outcomes are required prior to a gene expression model being introduced in clinical practice. Trial registration number No
Zitieren
APA
Sfakianoudis, K., Maziotis, E., Trypidi, A., Tsagkaraki, D., Androutsopoulou, M., Toska, A., Pantou, A., Grigoriadis, S., Chronopoulou, M., Pousias, S., Tzonis, P., Simopoulou, M., & Pantos, K. (2026). L26/P-335 The role of molecular profiling on investigating diagnostic approaches for chronic endometritis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.671
Vancouver
Sfakianoudis K, Maziotis E, Trypidi A, Tsagkaraki D, Androutsopoulou M, Toska A, et al. L26/P-335 The role of molecular profiling on investigating diagnostic approaches for chronic endometritis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.671
BibTeX
@article{Sfakianoudis2026,
author = {Sfakianoudis, K. and Maziotis, E. and Trypidi, A. and Tsagkaraki, D. and Androutsopoulou, M. and Toska, A. and Pantou, A. and Grigoriadis, S. and Chronopoulou, M. and Pousias, S. and Tzonis, P. and Simopoulou, M. and Pantos, K.},
title = {L26/P-335 The role of molecular profiling on investigating diagnostic approaches for chronic endometritis},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.671}
}
EUVIMED